265 related articles for article (PubMed ID: 21114861)
1. Current concepts regarding the HTLV-1 receptor complex.
Ghez D; Lepelletier Y; Jones KS; Pique C; Hermine O
Retrovirology; 2010 Nov; 7():99. PubMed ID: 21114861
[TBL] [Abstract][Full Text] [Related]
2. Interaction between the HTLV-1 envelope and cellular proteins: impact on virus infection and restriction.
Ilinskaya A; Heidecker G; Jones K
Future Med Chem; 2010 Nov; 2(11):1651-68. PubMed ID: 21428837
[TBL] [Abstract][Full Text] [Related]
3. HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165.
Lambert S; Bouttier M; Vassy R; Seigneuret M; Petrow-Sadowski C; Janvier S; Heveker N; Ruscetti FW; Perret G; Jones KS; Pique C
Blood; 2009 May; 113(21):5176-85. PubMed ID: 19270265
[TBL] [Abstract][Full Text] [Related]
4. Molecular aspects of HTLV-1 entry: functional domains of the HTLV-1 surface subunit (SU) and their relationships to the entry receptors.
Jones KS; Lambert S; Bouttier M; Bénit L; Ruscetti FW; Hermine O; Pique C
Viruses; 2011 Jun; 3(6):794-810. PubMed ID: 21994754
[TBL] [Abstract][Full Text] [Related]
5. Entry of human T-cell leukemia virus type 1 is augmented by heparin sulfate proteoglycans bearing short heparin-like structures.
Tanaka A; Jinno-Oue A; Shimizu N; Hoque A; Mori T; Islam S; Nakatani Y; Shinagawa M; Hoshino H
J Virol; 2012 Mar; 86(6):2959-69. PubMed ID: 22238310
[TBL] [Abstract][Full Text] [Related]
6. DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells.
Jain P; Manuel SL; Khan ZK; Ahuja J; Quann K; Wigdahl B
J Virol; 2009 Nov; 83(21):10908-21. PubMed ID: 19692463
[TBL] [Abstract][Full Text] [Related]
7. Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 use different receptor complexes to enter T cells.
Jones KS; Fugo K; Petrow-Sadowski C; Huang Y; Bertolette DC; Lisinski I; Cushman SW; Jacobson S; Ruscetti FW
J Virol; 2006 Sep; 80(17):8291-302. PubMed ID: 16912281
[TBL] [Abstract][Full Text] [Related]
8. The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2.
Jones KS; Huang YK; Chevalier SA; Afonso PV; Petrow-Sadowski C; Bertolette DC; Gessain A; Ruscetti FW; Mahieux R
J Virol; 2009 May; 83(10):5244-55. PubMed ID: 19279090
[TBL] [Abstract][Full Text] [Related]
9. Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.
Ghez D; Lepelletier Y; Lambert S; Fourneau JM; Blot V; Janvier S; Arnulf B; van Endert PM; Heveker N; Pique C; Hermine O
J Virol; 2006 Jul; 80(14):6844-54. PubMed ID: 16809290
[TBL] [Abstract][Full Text] [Related]
10. HTLV-1 Tax-1 interacts with SNX27 to regulate cellular localization of the HTLV-1 receptor molecule, GLUT1.
Al-Saleem J; Dirksen WP; Martinez MP; Shkriabai N; Kvaratskhelia M; Ratner L; Green PL
PLoS One; 2019; 14(3):e0214059. PubMed ID: 30897179
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells.
Jones KS; Petrow-Sadowski C; Bertolette DC; Huang Y; Ruscetti FW
J Virol; 2005 Oct; 79(20):12692-702. PubMed ID: 16188972
[TBL] [Abstract][Full Text] [Related]
12. GLUT1 is not the primary binding receptor but is associated with cell-to-cell transmission of human T-cell leukemia virus type 1.
Takenouchi N; Jones KS; Lisinski I; Fugo K; Yao K; Cushman SW; Ruscetti FW; Jacobson S
J Virol; 2007 Feb; 81(3):1506-10. PubMed ID: 17108050
[TBL] [Abstract][Full Text] [Related]
13. The N93D mutation of the human T-cell leukemia virus type 1 envelope glycoprotein found in symptomatic patients enhances neuropilin-1 b1 domain binding.
Kusunoki H; Tanaka T; Ohshima C; Sakamoto T; Wakamatsu K; Hamaguchi I
Biochim Biophys Acta Proteins Proteom; 2021 Nov; 1869(11):140708. PubMed ID: 34343702
[TBL] [Abstract][Full Text] [Related]
14. HTLV-1 sweet-talks its way into cells.
Overbaugh J
Nat Med; 2004 Jan; 10(1):20-1. PubMed ID: 14702624
[No Abstract] [Full Text] [Related]
15. Soluble recombinant HTLV-1 surface glycoprotein competitively inhibits syncytia formation and viral infection of cells.
Jassal SR; Lairmore MD; Leigh-Brown AJ; Brighty DW
Virus Res; 2001 Oct; 78(1-2):17-34. PubMed ID: 11520577
[TBL] [Abstract][Full Text] [Related]
16. Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells.
Jones KS; Petrow-Sadowski C; Huang YK; Bertolette DC; Ruscetti FW
Nat Med; 2008 Apr; 14(4):429-36. PubMed ID: 18376405
[TBL] [Abstract][Full Text] [Related]
17. GLUT-1-independent infection of the glioblastoma/astroglioma U87 cells by the human T cell leukemia virus type 1.
Jin Q; Agrawal L; Vanhorn-Ali Z; Alkhatib G
Virology; 2006 Sep; 353(1):99-110. PubMed ID: 16781755
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of synapse-associated protein Dlg1 reduces syncytium formation induced by human T-cell leukemia virus type 1.
Yoshida S; Higuchi M; Shoji T; Yoshita M; Ishioka K; Takahashi M; Oie M; Tanaka Y; Uchiyama M; Fujii M
Virus Genes; 2008 Aug; 37(1):9-15. PubMed ID: 18461433
[TBL] [Abstract][Full Text] [Related]
19. HTLV-1 tropism and envelope receptor.
Manel N; Battini JL; Taylor N; Sitbon M
Oncogene; 2005 Sep; 24(39):6016-25. PubMed ID: 16155608
[TBL] [Abstract][Full Text] [Related]
20. Quantifying HTLV-I dynamics.
Asquith B; Bangham CR
Immunol Cell Biol; 2007 Jun; 85(4):280-6. PubMed ID: 17372609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
